Evidence map›Paper›PMID 26656685›Full record

ArticleJournal of virology2016

Molecular Evolution and Intraclade Recombination of Enterovirus D68 during the 2014 Outbreak in the United States.

Yi Tan, Ferdaus Hassan, Jennifer E Schuster, Ari Simenauer, Rangaraj Selvarangan, Rebecca A Halpin, Xudong Lin, Nadia Fedorova, Timothy B Stockwell, Tommy Tsan-Yuk Lam and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Yi TanInfectious Diseases Group, J. Craig Venter Institute, Rockville, Maryland, USA.
Ferdaus HassanDepartment of Pathology and Laboratory Medicine, Children's Mercy Hospitals and Clinics, Kansas City, Missouri, USA.
Jennifer E SchusterDepartment of Pediatrics, Children's Mercy Hospitals and Clinics, Kansas City, Missouri, USA.
Ari SimenauerInfectious Diseases Group, J. Craig Venter Institute, Rockville, Maryland, USA.
Rangaraj SelvaranganDepartment of Pathology and Laboratory Medicine, Children's Mercy Hospitals and Clinics, Kansas City, Missouri, USA.
Rebecca A HalpinInfectious Diseases Group, J. Craig Venter Institute, Rockville, Maryland, USA.
Xudong LinInfectious Diseases Group, J. Craig Venter Institute, Rockville, Maryland, USA.
Nadia FedorovaInfectious Diseases Group, J. Craig Venter Institute, Rockville, Maryland, USA.
Timothy B StockwellInfectious Diseases Group, J. Craig Venter Institute, Rockville, Maryland, USA.
Tommy Tsan-Yuk LamCentre of Influenza Research, School of Public Health, The University of Hong Kong, Hong Kong, China.
James D ChappellDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Tina V HartertDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Edward C HolmesMarie Bashir Institute for Infectious Diseases & Biosecurity, Charles Perkins Centre, School of Biological Sciences and Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.
Suman R DasInfectious Diseases Group, J. Craig Venter Institute, Rockville, Maryland, USA sdas@jcvi.org.ORCID http://orcid.org/0000-0003-2496-9724
J. Craig Venter Institute · USChildren's Mercy Hospital · USVanderbilt University · USThe University of Sydney · AUUniversity of Hong Kong · HK

Funding

Viral and Host Determinants of Infant and Childhood Allergy and AsthmaU19AI095227 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Christian Rosas-Salazar · 2011 to 2026
$34.9M
The J. Craig Venter Institute Genome Center for Infectious DiseasesU19AI110819 · NIAID · J. CRAIG VENTER INSTITUTE, INC. · PI TAN, GENE · 2014 to 2018
$29.7M
Regulation and Function of Polarity and Asymmetric Cell Division in ImmunityR01AI095277 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHANG, JOHN T · 2012 to 2016
$2.6M
Midcareer Investigator Patient-oriented Research Award in Bronchiolitis & AsthmaK24AI077930 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARTERT, TINA V · 2008 to 2017
$1.6M
NIAID NIH HHS AI U19-AI-095277NIAID NIH HHS K24 AI077930NIAID NIH HHS R01 AI095277NIAID NIH HHS U19 AI095227NIAID NIH HHS U19 AI110819NIAID NIH HHS U19-AI-110819NIAID NIH HHS U19-AI-95227
6 · The paper itself

Abstract

unlabelledIn August 2014, an outbreak of enterovirus D68 (EV-D68) occurred in North America, causing severe respiratory disease in children. Due to a lack of complete genome sequence data, there is only a limited understanding of the molecular evolution and epidemiology of EV-D68 during this outbreak, and it is uncertain whether the differing clinical manifestations of EV-D68 infection are associated with specific viral lineages. We developed a high-throughput complete genome sequencing pipeline for EV-D68 that produced a total of 59 complete genomes from respiratory samples with a 95% success rate, including 57 genomes from Kansas City, MO, collected during the 2014 outbreak. With these data in hand, we performed phylogenetic analyses of complete genome and VP1 capsid protein sequences. Notably, we observed considerable genetic diversity among EV-D68 isolates in Kansas City, manifest as phylogenetically distinct lineages, indicative of multiple introductions of this virus into the city. In addition, we identified an intersubclade recombination event within EV-D68, the first recombinant in this virus reported to date. Finally, we found no significant association between EV-D68 genetic variation, either lineages or individual mutations, and a variety of demographic and clinical variables, suggesting that host factors likely play a major role in determining disease severity. Overall, our study revealed the complex pattern of viral evolution within a single geographic locality during a single outbreak, which has implications for the design of effective intervention and prevention strategies. IMPORTANCE: Until recently, EV-D68 was considered to be an uncommon human pathogen, associated with mild respiratory illness. However, in 2014 EV-D68 was responsible for more than 1,000 disease cases in North America, including severe respiratory illness in children and acute flaccid myelitis, raising concerns about its potential impact on public health. Despite the emergence of EV-D68, a lack of full-length genome sequences means that little is known about the molecular evolution of this virus within a single geographic locality during a single outbreak. Here, we doubled the number of publicly available complete genome sequences of EV-D68 by performing high-throughput next-generation sequencing, characterized the evolutionary history of this outbreak in detail, identified a recombination event, and investigated whether there was any correlation between the demographic and clinical characteristics of the patients and the viral variant that infected them. Overall, these results will help inform the design of intervention strategies for EV-D68.

Indexed as

Disease OutbreaksGenetic VariationRecombination, GeneticAdolescentChildChild, PreschoolCluster AnalysisEnterovirus D, HumanEnterovirus InfectionsEvolution, MolecularFemaleGenome, ViralHigh-Throughput Nucleotide SequencingHumansInfantInfant, Newborn

Identifiers

PMID26656685
PMCPMC4733988
OpenAlexW2190942937

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.